Connect with us

International Circuit

Rite Aid, in partnership with the US department of health and human services

Rite Aid and the U.S. Department of Health and Human Services (HHS), together with BioReference Laboratories, Inc., an OPKO Health company, announced a ‘Back to School’ COVID-19 testing program offering students at New York State public schools the opportunity for free COVID-19 testing prior to or at the start of the 2021-2022 school year. Students will be tested using highly accurate RT-PCR laboratory-based COVID-19 tests.

The ‘Back to School’ program includes The Increasing Community Access to Testing (ICATT), which is a program that helps reduce disease spread in schools, ensures that schools are safe environments for learning, and supports the reopening of schools. The ICATT complements other U.S. government efforts to expand testing in schools, such as the Health and Human Services (HHS) Expanded Testing Initiative Hub Program announced in February, and the $10 billion funding announced by HHS in March through the CDC’s Epidemiology and Laboratory Capacity (ELC) Cooperative Agreement.

“Our work with HHS has enabled Rite Aid to be on the front lines of the pandemic since the beginning, doing our part to keep the communities we serve healthy,” said Jocelyn Konrad, executive vice president and chief pharmacy officer, Rite Aid. “Providing access to COVID-19 testing for school-aged children is critical, particularly for those who are not able to be vaccinated, as we continue to fight the pandemic and get closer to a return to normal.”

Digital results will be delivered to parents for students to bring to school. COVID-19 testing is voluntary and will be provided at no cost to the student’s family or to the school district for this program.

“As governor, my priorities are now the priorities of the people of New York — and right now that means fighting the Delta variant,” Gov. Kathy Hochul said. “Number one on the list is getting children back to school and protecting the environment so they can learn safely. As a part of our efforts, we are launching a ‘Back to School’ COVID-19 testing program to make testing for students and staff widely available and convenient. We are proud to partner with the U.S. Department of Health and Human Services, BioReference and Rite Aid on this important initiative.”

“BioReference is proud to continue supporting New York State’s active surveillance programs with this ‘Back to School’ testing program,” said Jon R. Cohen, M.D., Executive Chairman of BioReference Laboratories. “It is imperative that we support programs that help to provide a safe environment for students to return to in-classroom learning.” Business Wire

Copyright © 2024 Medical Buyer

error: Content is protected !!